Results 71 to 80 of about 206,755 (278)
Platelet Refractoriness and HLA Matched Platelets Slidedeck
Slide deck summarizing causes of platelet refractoriness and transfusion strategies for immune-refractoriness including HLA-matched versus crossmatch-compatible platelets.
David Allison (9094295)
core +1 more source
ABSTRACT Diabetic wounds are characterized by persistent inflammation and impaired immune resolution, yet the therapeutic translation of single‐cell atlases into rational immunomodulatory strategies remains limited. Here, integration of diabetic‐wound single‐cell transcriptomic datasets identifies a neutrophil subpopulation enriched in cluster of ...
Tairong Cui +12 more
wiley +1 more source
ABSTRACT Aim Although randomized trials have discouraged routine prophylactic abdominal drainage after uncomplicated hepatectomy, these drains are still widely used in clinical practice. This study evaluated the association between prophylactic abdominal drain placement and short‐term outcomes after hepatic resection using a nationwide inpatient ...
Keita Kouzu +17 more
wiley +1 more source
A unifying device–cardiovascular interface framework is presented to classify implantable cardiovascular technologies as intracardiovascular blood‐contacting systems or extracardiovascular tissue‐only and blood‐handling architectures. Cross‐class comparison across shared semiquantitative criteria, including blood‐contact burden, biomimicry ...
Bergo Nicolò +7 more
wiley +1 more source
Management of Patients Refractory to Platelet Transfusion
Abstract Objective. —To present a current assessment and practical approach to the diagnosis and management of patients who are refractory to platelet transfusions. Design. —A task force was convened by the College of
Ronald A, Sacher +5 more
openaire +2 more sources
ABSTRACT Nodal T‐follicular helper cell lymphoma (nTFHL), most commonly of angioimmunoblastic type, exhibits heterogeneous clinical outcomes that are not fully explained by current clinical and biological variables. While genetic alterations have been extensively investigated, its proteomic landscape remains largely unexplored.
David Beauvais +9 more
wiley +1 more source
ABSTRACT Pirtobrutinib, a highly selective, non‐covalent Bruton tyrosine kinase inhibitor (BTKi) previously demonstrated durable efficacy and tolerable safety following covalent (c) BTKi therapy in heavily pretreated relapsed/refractory (R/R) mantle cell lymphoma (MCL).
Michael L. Wang +36 more
wiley +1 more source
Antiplatelet antibodies in patients with ITP and patient with platelet refractoriness
Background: Immune thrombocytopenic purpura is an acquired disorder, in which accelerated platelet consumption is due to PLT autoantibodies. The diagnosis of immune thrombocytopenic purpura is a diagnosis of exclusion.
Salah Aref, Lamiaa Ebrahim, Tarek Selim
doaj
[Objective] To evaluate the performance of platelet efficacy score (PEscore) in predicting platelet transfusion efficacy in hematological patients. [Methods] A total of 485 patients with hematological diseases, including 298 males (62.09±15.45 years) and
LI Jun +4 more
doaj +1 more source

